OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Jill Wechsler is BioPharm International's Washington Editor, firstname.lastname@example.org.
November 02, 2020
Experts fear confusion over allocation processes, cold-chain requirements, and IT systems needed to bring a COVID-19 vaccine to market.
September 02, 2020
Regulators strive to review flood of advanced treatments while also vetting COVID-19 vaccines.
August 24, 2020
FDA announced it had issued an emergency use authorization for convalescent plasma that would make it easier to provide this treatment to COVID-19 patients.
December 02, 2019
Problems in assuring reliable drug quality and supply dampens progress in bringing lifesaving therapies to market.